immunoselection

im·mu·no·se·lec·tion

(im'yū-nō-se-lek'shŭn),
1. Selective death or survival of fetuses of different genotypes depending on immunologic incompatibility with the mother.
2. The survival of certain cells depending on their surface antigenicity.

immunoselection

[-silek′shən]
Etymology: L, immunis + seligere, to select
the survival of certain cells as a result of their lack of surface antigens that would otherwise make them vulnerable to attack and destruction by antibodies. See also erythroblastosis fetalis, Rh factor.

immunoselection

(ĭm″ū-nō-sĕ-lĕk′shŭn)
The enhanced survival of cells or organisms that have favorable cell surface markers. The antigens allow the cells organisms to escape destruction by humoral or cell-mediated immunity.
References in periodicals archive ?
26) Detection of these rare events has been improved by advances in cell capture technology, including positive or negative immunoselection, microfluidics, size, and other physical properties to select epithelial cells from the majority leukocytes.
Ficoll centrifugation), ability to invade a collagen matrix, and positive immunoselection [e.
immunoselection with EpCAM antibodies cannot catch EpCAM-negative CTCs).
Red blood cell depletion and enrichment of CD34+ hematopoietic progenitor cells from human umbilical cord blood using soybean agglutinin and CD34 immunoselection.
Cancer despite immunosurveillance: immunoselection and immunosubversion Nature Rev Immunol 2006; 6 : 715-27.
These clinical trials" says Murdock, "will allow CellPro to continue development of the immunoselection technology used in the CEPRATE(R) SC System.
Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma.
For a definitive confirmation, the patient's serum was assayed by a immunoselection method.
The selection of cells by immunoselection has broad utility in the development of cell therapies.
The separation of cells by immunoselection has broad utility in the development of cell therapies.
In addition," says Culver, "development of this product, which is based on the same immunoselection technology utilized in the CEPRATE SC System, demonstrates the versatility of CellPro's core technology platform.